Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 256 entries
Sorted by: Best Match Show Resources per page
Disease proportions attributable to environment

interventions

Vineis P.
GSID: j4Q_aelmY8UJ
R Saracci, P Vineis - Environmental Health, 2007 - Springer

Population disease proportions attributable to various causal agents are popular as they present a simplified view of the contribution of each agent to the disease load. However they …

Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide.

Journal of the National Cancer Institute

Bray F, Jemal A, Torre LA, Forman D, Vineis P.
PMID: 26424777
J Natl Cancer Inst. 2015 Sep 30;107(12):djv273. doi: 10.1093/jnci/djv273. Print 2015 Dec.

The global figure of 14 million new cancer cases in 2012 is projected to rise to almost 22 million by 2030, with the burden in low- and middle-income countries (LMICs) shifting from 59% to 65% of all cancer cases...

Cite
Bray F, Jemal A, Torre LA, et al. Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. J Natl Cancer Inst. 2015;107(12):djv273doi: 10.1093/jnci/djv273.
Bray, F., Jemal, A., Torre, L. A., Forman, D., & Vineis, P. (2015). Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. Journal of the National Cancer Institute, 107(12), djv273. https://doi.org/10.1093/jnci/djv273
Bray, Freddie, et al. "Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide." Journal of the National Cancer Institute vol. 107,12 (2015): djv273. doi: https://doi.org/10.1093/jnci/djv273
Bray F, Jemal A, Torre LA, Forman D, Vineis P. Long-term Realism and Cost-effectiveness: Primary Prevention in Combatting Cancer and Associated Inequalities Worldwide. J Natl Cancer Inst. 2015 Sep 30;107(12):djv273. doi: 10.1093/jnci/djv273. Print 2015 Dec. PMID: 26424777; PMCID: PMC4673394.
Copy Download .nbib Format: NLM
Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer.

Nature genetics

Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI.
PMID: 28358128
Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a.

No abstract available.

Cite
Wang Y, McKay JD, Rafnar T, et al. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017;49(4):651doi: 10.1038/ng0417-651a.
Wang, Y., McKay, J. D., Rafnar, T., Wang, Z., Timofeeva, M. N., Broderick, P., Zong, X., Laplana, M., Wei, Y., Han, Y., Lloyd, A., Delahaye-Sourdeix, M., Chubb, D., Gaborieau, V., Wheeler, W., Chatterjee, N., Thorleifsson, G., Sulem, P., Liu, G., Kaaks, R., Henrion, M., Kinnersley, B., Vallée, M., Le Calvez-Kelm, F., Stevens, V. L., Gapstur, S. M., Chen, W. V., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., Fabianova, E., Mates, D., Bencko, V., Foretova, L., Janout, V., Krokan, H. E., Gabrielsen, M. E., Skorpen, F., Vatten, L., Njølstad, I., Chen, C., Goodman, G., Benhamou, S., Vooder, T., Välk, K., Nelis, M., Metspalu, A., Lener, M., Lubiński, J., Johansson, M., Vineis, P., Agudo, A., Clavel-Chapelon, F., Bueno-de-Mesquita, H. B., Trichopoulos, D., Khaw, K. T., Johansson, M., Weiderpass, E., Tjønneland, A., Riboli, E., Lathrop, M., Scelo, G., Albanes, D., Caporaso, N. E., Ye, Y., Gu, J., Wu, X., Spitz, M. R., Dienemann, H., Rosenberger, A., Su, L., Matakidou, A., Eisen, T., Stefansson, K., Risch, A., Chanock, S. J., Christiani, D. C., Hung, R. J., Brennan, P., Landi, M. T., Houlston, R. S., & Amos, C. I. (2017). Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nature genetics, 49(4), 651. https://doi.org/10.1038/ng0417-651a
Wang, Yufei, et al. "Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer." Nature genetics vol. 49,4 (2017): 651. doi: https://doi.org/10.1038/ng0417-651a
Wang Y, McKay JD, Rafnar T, Wang Z, Timofeeva MN, Broderick P, Zong X, Laplana M, Wei Y, Han Y, Lloyd A, Delahaye-Sourdeix M, Chubb D, Gaborieau V, Wheeler W, Chatterjee N, Thorleifsson G, Sulem P, Liu G, Kaaks R, Henrion M, Kinnersley B, Vallée M, Le Calvez-Kelm F, Stevens VL, Gapstur SM, Chen WV, Zaridze D, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Krokan HE, Gabrielsen ME, Skorpen F, Vatten L, Njølstad I, Chen C, Goodman G, Benhamou S, Vooder T, Välk K, Nelis M, Metspalu A, Lener M, Lubiński J, Johansson M, Vineis P, Agudo A, Clavel-Chapelon F, Bueno-de-Mesquita HB, Trichopoulos D, Khaw KT, Johansson M, Weiderpass E, Tjønneland A, Riboli E, Lathrop M, Scelo G, Albanes D, Caporaso NE, Ye Y, Gu J, Wu X, Spitz MR, Dienemann H, Rosenberger A, Su L, Matakidou A, Eisen T, Stefansson K, Risch A, Chanock SJ, Christiani DC, Hung RJ, Brennan P, Landi MT, Houlston RS, Amos CI. Corrigendum: Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer. Nat Genet. 2017 Mar 30;49(4):651. doi: 10.1038/ng0417-651a. PMID: 28358128.
Copy Download .nbib Format: NLM
Methods for Measuring Autophagy in Mice.

Cells

Moulis M, Vindis C.
PMID: 28594368
Cells. 2017 Jun 08;6(2). doi: 10.3390/cells6020014.

Autophagy is a dynamic intracellular process that mediates the degradation of damaged cytoplasmic components by the lysosome. This process plays important roles in maintaining normal cellular homeostasis and energy balance. Measuring autophagy activity is critical and although the determination...

Cite
Moulis M, Vindis C. Methods for Measuring Autophagy in Mice. Cells. 2017;6(2)doi: 10.3390/cells6020014.
Moulis, M., & Vindis, C. (2017). Methods for Measuring Autophagy in Mice. Cells, 6(2), . https://doi.org/10.3390/cells6020014
Moulis, Manon, and Vindis, Cécile. "Methods for Measuring Autophagy in Mice." Cells vol. 6,2 (2017). doi: https://doi.org/10.3390/cells6020014
Moulis M, Vindis C. Methods for Measuring Autophagy in Mice. Cells. 2017 Jun 08;6(2). doi: 10.3390/cells6020014. PMID: 28594368; PMCID: PMC5492018.
Copy Download .nbib Format: NLM
Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology

Sionova M, Blasko P, Jirous S, Vindis D, Rokyta R, Motovska Z.
PMID: 29056992
Postepy Kardiol Interwencyjnej. 2017;13(3):202-209. doi: 10.5114/aic.2017.70187. Epub 2017 Sep 25.

INTRODUCTION: Periprocedural bleeding related to coronary angiography (CAG) or percutaneous coronary intervention (PCI) is associated with worse prognosis. Determining genetic variations associated with increased bleeding risk may help to identify high-risk patients.AIM: To analyse the association between single nucleotide...

Cite
Sionova M, Blasko P, Jirous S, et al. Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention. Postepy Kardiol Interwencyjnej. 2017;13(3):202-209doi: 10.5114/aic.2017.70187.
Sionova, M., Blasko, P., Jirous, S., Vindis, D., Rokyta, R., & Motovska, Z. (2017). Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention. Postepy w kardiologii interwencyjnej = Advances in interventional cardiology, 13(3), 202-209. https://doi.org/10.5114/aic.2017.70187
Sionova, Magdalena, et al. "Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention." Postepy w kardiologii interwencyjnej = Advances in interventional cardiology vol. 13,3 (2017): 202-209. doi: https://doi.org/10.5114/aic.2017.70187
Sionova M, Blasko P, Jirous S, Vindis D, Rokyta R, Motovska Z. Association of polymorphisms of platelet receptors GPIa (807C>T), GPVI (13254T>C), and P2Y12 (34C>T and H1/H2 haplotype) with increased risk of periprocedural bleeding in patients undergoing coronary angiography/percutaneous coronary intervention. Postepy Kardiol Interwencyjnej. 2017;13(3):202-209. doi: 10.5114/aic.2017.70187. Epub 2017 Sep 25. PMID: 29056992; PMCID: PMC5644038.
Copy Download .nbib Format: NLM
Production of Farmstead Lactose-Free .

Italian journal of food safety

Pulinas L, Spanu C, Idda I, Ibba I, Nieddu G, Virdis S, Scarano C, Piras F, Spano N, Sanna G, De Santis EPL.
PMID: 28462205
Ital J Food Saf. 2017 Feb 17;6(1):6353. doi: 10.4081/ijfs.2017.6353. eCollection 2017 Jan 24.

The present work was aimed to define and validate farmstead production of lactose-free

Cite
Pulinas L, Spanu C, Idda I, et al. Production of Farmstead Lactose-Free . Ital J Food Saf. 2017;6(1):6353doi: 10.4081/ijfs.2017.6353.
Pulinas, L., Spanu, C., Idda, I., Ibba, I., Nieddu, G., Virdis, S., Scarano, C., Piras, F., Spano, N., Sanna, G., & De Santis, E. P. L. (2017). Production of Farmstead Lactose-Free . Italian journal of food safety, 6(1), 6353. https://doi.org/10.4081/ijfs.2017.6353
Pulinas, Luisa, et al. "Production of Farmstead Lactose-Free ." Italian journal of food safety vol. 6,1 (2017): 6353. doi: https://doi.org/10.4081/ijfs.2017.6353
Pulinas L, Spanu C, Idda I, Ibba I, Nieddu G, Virdis S, Scarano C, Piras F, Spano N, Sanna G, De Santis EPL. Production of Farmstead Lactose-Free . Ital J Food Saf. 2017 Feb 17;6(1):6353. doi: 10.4081/ijfs.2017.6353. eCollection 2017 Jan 24. PMID: 28462205; PMCID: PMC5391506.
Copy Download .nbib Format: NLM
Global prevention and control of NCDs: Limitations of the standard approach.

Journal of public health policy

Pearce N, Ebrahim S, McKee M, Lamptey P, Barreto ML, Matheson D, Walls H, Foliaki S, Miranda JJ, Chimeddamba O, Garcia-Marcos L, Haines A, Vineis P.
PMID: 26377446
J Public Health Policy. 2015 Nov;36(4):408-25. doi: 10.1057/jphp.2015.29. Epub 2015 Sep 17.

The five-target '25 × 25' strategy for tackling the emerging global epidemic of non-communicable diseases (NCDs) focuses on four diseases (CVD, diabetes, cancer, and chronic respiratory disease), four risk factors (tobacco, diet and physical activity, dietary salt, and alcohol),...

Cite
Pearce N, Ebrahim S, McKee M, et al. Global prevention and control of NCDs: Limitations of the standard approach. J Public Health Policy. 2015;36(4):408-25doi: 10.1057/jphp.2015.29.
Pearce, N., Ebrahim, S., McKee, M., Lamptey, P., Barreto, M. L., Matheson, D., Walls, H., Foliaki, S., Miranda, J. J., Chimeddamba, O., Garcia-Marcos, L., Haines, A., & Vineis, P. (2015). Global prevention and control of NCDs: Limitations of the standard approach. Journal of public health policy, 36(4), 408-25. https://doi.org/10.1057/jphp.2015.29
Pearce, Neil, et al. "Global prevention and control of NCDs: Limitations of the standard approach." Journal of public health policy vol. 36,4 (2015): 408-25. doi: https://doi.org/10.1057/jphp.2015.29
Pearce N, Ebrahim S, McKee M, Lamptey P, Barreto ML, Matheson D, Walls H, Foliaki S, Miranda JJ, Chimeddamba O, Garcia-Marcos L, Haines A, Vineis P. Global prevention and control of NCDs: Limitations of the standard approach. J Public Health Policy. 2015 Nov;36(4):408-25. doi: 10.1057/jphp.2015.29. Epub 2015 Sep 17. PMID: 26377446.
Copy Download .nbib Format: NLM
Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection.

Current epidemiology reports

Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V, Micallef CM, Vineis P, Rushton L, Bray F, Soerjomataram I.
PMID: 27547696
Curr Epidemiol Rep. 2016 Sep;3(3):201-211. doi: 10.1007/s40471-016-0085-5. Epub 2016 Aug 01.

The proportions of new cancer cases and deaths that are caused by exposure to risk factors and that could be prevented are key statistics for public health policy and planning. This paper summarizes the methodologies for estimating, challenges in...

Cite
Shield KD, Parkin DM, Whiteman DC, et al. Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep. 2016;3(3):201-211doi: 10.1007/s40471-016-0085-5.
Shield, K. D., Parkin, D. M., Whiteman, D. C., Rehm, J., Viallon, V., Micallef, C. M., Vineis, P., Rushton, L., Bray, F., & Soerjomataram, I. (2016). Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Current epidemiology reports, 3(3), 201-211. https://doi.org/10.1007/s40471-016-0085-5
Shield, Kevin D, et al. "Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection." Current epidemiology reports vol. 3,3 (2016): 201-211. doi: https://doi.org/10.1007/s40471-016-0085-5
Shield KD, Parkin DM, Whiteman DC, Rehm J, Viallon V, Micallef CM, Vineis P, Rushton L, Bray F, Soerjomataram I. Population Attributable and Preventable Fractions: Cancer Risk Factor Surveillance, and Cancer Policy Projection. Curr Epidemiol Rep. 2016 Sep;3(3):201-211. doi: 10.1007/s40471-016-0085-5. Epub 2016 Aug 01. PMID: 27547696; PMCID: PMC4990141.
Copy Download .nbib Format: NLM
Prognostic role of .

Oncology letters

Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G.
PMID: 27446446
Oncol Lett. 2016 Aug;12(2):1415-1421. doi: 10.3892/ol.2016.4798. Epub 2016 Jun 29.

The presence of mutations in the KRAS gene is a predictor of a poor clinical response to EGFR-targeted agents in patients affected by colorectal cancer (CRC), but its significance as a global prognostic factor remains unclear. The aim of...

Cite
Palomba G, Cossu A, Paliogiannis P, et al. Prognostic role of . Oncol Lett. 2016;12(2):1415-1421doi: 10.3892/ol.2016.4798.
Palomba, G., Cossu, A., Paliogiannis, P., Pazzola, A., Baldino, G., Scartozzi, M., Ionta, M. T., Ortu, S., Capelli, F., Lanzillo, A., Sedda, T., Sanna, G., Barca, M., Virdis, L., Budroni, M., & Palmieri, G. (2016). Prognostic role of . Oncology letters, 12(2), 1415-1421. https://doi.org/10.3892/ol.2016.4798
Palomba, Grazia, et al. "Prognostic role of ." Oncology letters vol. 12,2 (2016): 1415-1421. doi: https://doi.org/10.3892/ol.2016.4798
Palomba G, Cossu A, Paliogiannis P, Pazzola A, Baldino G, Scartozzi M, Ionta MT, Ortu S, Capelli F, Lanzillo A, Sedda T, Sanna G, Barca M, Virdis L, Budroni M, Palmieri G. Prognostic role of . Oncol Lett. 2016 Aug;12(2):1415-1421. doi: 10.3892/ol.2016.4798. Epub 2016 Jun 29. PMID: 27446446; PMCID: PMC4950545.
Copy Download .nbib Format: NLM
Erratum to: Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.

BMC musculoskeletal disorders

Fisher BA, Cartwright AJ, Quirke AM, de Pablo P, Romaguera D, Panico S, Mattiello A, Gavrila D, Navarro C, Sacerdote C, Vineis P, Tumino R, Lappin DF, Apatzidou D, Culshaw S, Potempa J, Michaud DS, Riboli E, Venables PJ.
PMID: 26849877
BMC Musculoskelet Disord. 2016 Feb 05;17:62. doi: 10.1186/s12891-016-0916-z.

No abstract available.

Cite
Fisher BA, Cartwright AJ, Quirke AM, et al. Erratum to: Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study. BMC Musculoskelet Disord. 2016;17:62doi: 10.1186/s12891-016-0916-z.
Fisher, B. A., Cartwright, A. J., Quirke, A. M., de Pablo, P., Romaguera, D., Panico, S., Mattiello, A., Gavrila, D., Navarro, C., Sacerdote, C., Vineis, P., Tumino, R., Lappin, D. F., Apatzidou, D., Culshaw, S., Potempa, J., Michaud, D. S., Riboli, E., & Venables, P. J. (2016). Erratum to: Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study. BMC musculoskeletal disorders, 1762. https://doi.org/10.1186/s12891-016-0916-z
Fisher, Benjamin A, et al. "Erratum to: Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study." BMC musculoskeletal disorders vol. 17 (2016): 62. doi: https://doi.org/10.1186/s12891-016-0916-z
Fisher BA, Cartwright AJ, Quirke AM, de Pablo P, Romaguera D, Panico S, Mattiello A, Gavrila D, Navarro C, Sacerdote C, Vineis P, Tumino R, Lappin DF, Apatzidou D, Culshaw S, Potempa J, Michaud DS, Riboli E, Venables PJ. Erratum to: Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study. BMC Musculoskelet Disord. 2016 Feb 05;17:62. doi: 10.1186/s12891-016-0916-z. PMID: 26849877; PMCID: PMC4744449.
Copy Download .nbib Format: NLM
Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis.

Clinical epigenetics

van Veldhoven K, Polidoro S, Baglietto L, Severi G, Sacerdote C, Panico S, Mattiello A, Palli D, Masala G, Krogh V, Agnoli C, Tumino R, Frasca G, Flower K, Curry E, Orr N, Tomczyk K, Jones ME, Ashworth A, Swerdlow A, Chadeau-Hyam M, Lund E, Garcia-Closas M, Sandanger TM, Flanagan JM, Vineis P.
PMID: 26244061
Clin Epigenetics. 2015 Aug 04;7:67. doi: 10.1186/s13148-015-0104-2. eCollection 2015.

BACKGROUND: Interest in the potential of DNA methylation in peripheral blood as a biomarker of cancer risk is increasing. We aimed to assess whether epigenome-wide DNA methylation measured in peripheral blood samples obtained before onset of the disease is...

Cite
van Veldhoven K, Polidoro S, Baglietto L, et al. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics. 2015;7:67doi: 10.1186/s13148-015-0104-2.
van Veldhoven, K., Polidoro, S., Baglietto, L., Severi, G., Sacerdote, C., Panico, S., Mattiello, A., Palli, D., Masala, G., Krogh, V., Agnoli, C., Tumino, R., Frasca, G., Flower, K., Curry, E., Orr, N., Tomczyk, K., Jones, M. E., Ashworth, A., Swerdlow, A., Chadeau-Hyam, M., Lund, E., Garcia-Closas, M., Sandanger, T. M., Flanagan, J. M., & Vineis, P. (2015). Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clinical epigenetics, 767. https://doi.org/10.1186/s13148-015-0104-2
van Veldhoven, Karin, et al. "Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis." Clinical epigenetics vol. 7 (2015): 67. doi: https://doi.org/10.1186/s13148-015-0104-2
van Veldhoven K, Polidoro S, Baglietto L, Severi G, Sacerdote C, Panico S, Mattiello A, Palli D, Masala G, Krogh V, Agnoli C, Tumino R, Frasca G, Flower K, Curry E, Orr N, Tomczyk K, Jones ME, Ashworth A, Swerdlow A, Chadeau-Hyam M, Lund E, Garcia-Closas M, Sandanger TM, Flanagan JM, Vineis P. Epigenome-wide association study reveals decreased average methylation levels years before breast cancer diagnosis. Clin Epigenetics. 2015 Aug 04;7:67. doi: 10.1186/s13148-015-0104-2. eCollection 2015. PMID: 26244061; PMCID: PMC4524428.
Copy Download .nbib Format: NLM
Characterization of whole-genome autosomal differences of DNA methylation between men and women.

Epigenetics & chromatin

Singmann P, Shem-Tov D, Wahl S, Grallert H, Fiorito G, Shin SY, Schramm K, Wolf P, Kunze S, Baran Y, Guarrera S, Vineis P, Krogh V, Panico S, Tumino R, Kretschmer A, Gieger C, Peters A, Prokisch H, Relton CL, Matullo G, Illig T, Waldenberger M, Halperin E.
PMID: 26500701
Epigenetics Chromatin. 2015 Oct 19;8:43. doi: 10.1186/s13072-015-0035-3. eCollection 2015.

BACKGROUND: Disease risk and incidence between males and females reveal differences, and sex is an important component of any investigation of the determinants of phenotypes or disease etiology. Further striking differences between men and women are known, for instance,...

Cite
Singmann P, Shem-Tov D, Wahl S, et al. Characterization of whole-genome autosomal differences of DNA methylation between men and women. Epigenetics Chromatin. 2015;8:43doi: 10.1186/s13072-015-0035-3.
Singmann, P., Shem-Tov, D., Wahl, S., Grallert, H., Fiorito, G., Shin, S. Y., Schramm, K., Wolf, P., Kunze, S., Baran, Y., Guarrera, S., Vineis, P., Krogh, V., Panico, S., Tumino, R., Kretschmer, A., Gieger, C., Peters, A., Prokisch, H., Relton, C. L., Matullo, G., Illig, T., Waldenberger, M., & Halperin, E. (2015). Characterization of whole-genome autosomal differences of DNA methylation between men and women. Epigenetics & chromatin, 843. https://doi.org/10.1186/s13072-015-0035-3
Singmann, Paula, et al. "Characterization of whole-genome autosomal differences of DNA methylation between men and women." Epigenetics & chromatin vol. 8 (2015): 43. doi: https://doi.org/10.1186/s13072-015-0035-3
Singmann P, Shem-Tov D, Wahl S, Grallert H, Fiorito G, Shin SY, Schramm K, Wolf P, Kunze S, Baran Y, Guarrera S, Vineis P, Krogh V, Panico S, Tumino R, Kretschmer A, Gieger C, Peters A, Prokisch H, Relton CL, Matullo G, Illig T, Waldenberger M, Halperin E. Characterization of whole-genome autosomal differences of DNA methylation between men and women. Epigenetics Chromatin. 2015 Oct 19;8:43. doi: 10.1186/s13072-015-0035-3. eCollection 2015. PMID: 26500701; PMCID: PMC4615866.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 256 entries